Cardio Diagnostics Holdings, Inc. (CDIO) Cash and securities
- Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30..
Cash and securities
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | (m) | Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 0.00 USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $0.00 | (m) | (m) |
| 2026-03-31 | (m) | (m) | $0.00 | (m) | (m) |
| 2025-12-31 | (m) | (m) | $0.00 | (m) | (m) |
| 2025-09-30 | (m) | (m) | $0.00 | (m) | (m) |
| 2025-06-30 | (m) | (m) | $0.00 | (m) | (m) |
| 2025-03-31 | (m) | (m) | $0.00 | (m) | (m) |
| 2024-12-31 | (m) | (m) | $0.00 | (m) | (m) |
| 2024-09-30 | (m) | (m) | $0.00 | (m) | (m) |
| 2024-06-30 | (m) | (m) | $0.00 | (m) | (m) |
| 2024-03-31 | (m) | (m) | $0.00 | (m) | (m) |
| 2023-12-31 | (m) | (m) | $0.00 | (m) | (m) |
| 2023-09-30 | (m) | (m) | $0.00 | (m) | (m) |
| 2023-06-30 | (m) | (m) | $0.00 | (m) | (m) |
| 2023-03-31 | (m) | (m) | $0.00 | (m) | (m) |
| 2022-12-31 | (m) | (m) | $0.00 | (m) | (m) |
| 2022-09-30 | (m) | (m) | $0.00 | (m) | (m) |
| 2022-06-30 | (m) | (m) | $0.00 | (m) | (m) |
| 2022-03-31 | (m) | (m) | $0.00 | (m) | (m) |
| 2021-12-31 | (m) | (m) | $0.00 | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |